trial

Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia

NCTId NCT01382433
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 115 (estimated)
Sponsored by Shalvata Mental Health Center
Primary completion 2012-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
115 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2011-07
Primary completion
2012-07
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
Magnetoencephalograph (MEG)Cambridge Neuropsychological Test Automated Battery (CANTAB).

Sponsors

Shalvata Mental Health CenterLead Sponsor

Investigators

1
Hilik Levkovitz, prof.Principal Investigator

Sites

1 total
Givat Shmuel, Israel

Facts & assertions

4 sourced
Enrollment
115
Phase
NA
Primary Completion Date
2012-07
Status
UNKNOWN
relationships
The graph out of here
drug
Magnetoencephalograph (MEG)
drug
Cambridge Neuropsychological Test Automated Battery (CANTAB).
drug
lead_sponsor
Shalvata Mental Health Center
company
indication
Chronic Cannabis Users
indication
Healthy Subjects
indication
investigator
Hilik Levkovitz, prof.
person